Finding new treatment targets for autoimmune hormone disorders.
Identifying new immunotherapeutic targets for endocrine autoimmunity.
This study is looking into how the immune system mistakenly attacks hormone-producing tissues in people with autoimmune endocrine disorders, and it aims to find new ways to treat these conditions by understanding how certain immune cells and genes work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10845206 on NIH RePORTER |
What this research studies
This research investigates autoimmune endocrinopathies, conditions where the immune system mistakenly attacks hormone-producing tissues. The project aims to understand the mechanisms behind these disorders, particularly focusing on how certain immune cells behave in these conditions. By exploring the role of specific genes and epigenetic factors, the research seeks to identify new targets for immunotherapy, which could lead to more effective treatments for patients suffering from these autoimmune diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autoimmune endocrinopathies, particularly women who are disproportionately affected by these conditions.
Not a fit: Patients with autoimmune conditions that do not involve endocrine tissues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new immunotherapy options for patients with autoimmune endocrinopathies, improving their treatment outcomes.
How similar studies have performed: While research on autoimmune diseases is extensive, the specific focus on immunotherapy for autoimmune endocrinopathies is relatively novel and has not been extensively tested.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Su, Maureen a — University of California Los Angeles
- Study coordinator: Su, Maureen a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.